Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 8 Positions - $5,426,819 in Compensation from 2008 to 2010

This is what the status quo'ers defend.

PTSC's 3 executive positions, CEO, CFO & VP, and it's 5 director positions have collected $5.43M from PTSC's coffers over the last 3 fiscal years. Flowers collecting the largest windfall at nearly $1.2M, and showing Turley & Goerner having VERY lucrative, albeit brief careers as PTSC CEO's. Our magnificent BOD members collectively rewarded themselves with a hefty $1.34M for stewarding our company to this precarious position.

In that time, PTSC has gone from having assets of $34.4M at the end of fiscal year 2007, to $25.4M at the end of the last quarter. And from having a share price of 51 cents on May 31, 2007, to a current price of 9.3 cents.

That's a loss of $9M in assets, and decrease from a market cap of $198.4M on May 31, 2007, to a current market cap of $38.2M DESPITE collecting in excess of $35M CLEAR in MMP revenue and having an additional 21M shares outstanding during that same time frame.

Collectively, the six of them that are still with the company own less than 2% of the company despite their gluttonous compensation relative to their performance.

Now they won't even meet face to face with people or respond to e-mails? Who really thinks these folks are working on our behalf?

CEO, CFO & VP -

  • 3 positions
  • $4,082,910 in total compensation
  • $1.36M per position

Breakdown:

  • Flowers - $1,185,452
  • Goerner - $1,136,103
  • Turley - $976,927
  • Pohl - $110,561
  • Sweeney - $117,688
  • Bibeau - $556,179

Board of Directors-

  • 5 positions
  • $1,343,909 in total compensation
  • $268K per position

Breakdown:

  • Johnson- $408,600
  • Felcyn - $328,00
  • Falk - $108,000
  • Treadenick - $140,763
  • Schrock - $184,546
  • Mistry - $102,000
  • Pohl - $72,000
Share
New Message
Please login to post a reply